BRAF and acute lymphoblastic leukemia: Nevertheless, it remains to be evaluated whether the assessment of BRAF levels at certain time points of therapy might help to stratify the intensity of treatment as it has been shown for minimal residual disease in acute lymphoblastic leukemia [15].